-The Business Standard Contrary to earlier claims, farm growth may be robust The projection by the Commission for Agricultural Costs and Prices (CACP) of robust agricultural growth of above five per cent and a consequential handsome rise in rural incomes comes as a silver lining to India's otherwise gloomy economic scene. The CACP's reckoning, based on a rigorous mathematical model, virtually discounts the agriculture ministry's kharif crop output estimates (called first advance...

-The Guardian     Indian farmers have seen increased yields not just in rice but also in wheat cultivation. Could SCI curb hunger in low-resource communities?     Yields achieved under the system of rice intensification (SRI) have made headlines in recent years, with one farmer in India reported to have produced a record-breaking 22.4 tonnes from one hectare of land in 2011. But why stop at rice? Farmers and NGOs have found that the same...

-Grist Media The proposed Food Security Bill will likely raise the demand for dal across India. While farmers and consumers are against it, the government keeps favouring the agri-industry and importing more and more cheap versions to offset rising inflation. But why won't India produce its own dal anymore? Nowhere are Canada's agricultural production plans tracked more closely than in India's Ministry of Food & Consumer Affairs. As it struggles to meet...

-Down to Earth A Sehore farmer finds a unique Pigeon Pea variety that bears pods three to four times in a row When their two soybean crops failed in two consecutive years, farmer Raj Kumar Rathore tried to convince his parents to experiment with other crops. But it only angered them. They were not ready to give up farming the traditional crop of Madhya Pradesh's Sehore district. He was ousted from the...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...